|
Dr. Osgood joined ThermoGenesis Corp. in January 2006 as General Manager of Operations, and currently serves as Chief Executive Officer. He brings more than 20 years of leadership experience in the operations of Class II and III medical device companies to the Company, and most recently served as Senior Vice President of Sorin Group Company's $250 million cardiopulmonary business, where he managed worldwide commercial operations and research and development for its intra-operative heart and lung devices and related disposables. Dr. Osgood joined Sorin after the company acquired COBE Cardiovascular Inc., where he led the industrial integration of plants worldwide. Prior to this, he was Vice President of Baxter Healthcare's $800 million CardioVascular Group, where he successfully reengineered business processes across multiple divisions resulting in sales growth, cost reductions and deeper customer partnerships. He holds a Ph.D. in Systems Engineering, a Masters Degree of Business Administration, a Masters Degree of Science in Control Theory and a Bachelor of Science Degree in Engineering from University of California, Los Angeles. | 